Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma. | Aging (Albany NY) | 2023 | 37211398 | PubTator, text mining | PubMed |
| Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates. | Front Immunol | 2023 | 37207227 | PubTator, text mining | PubMed |
| Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies. | Front Immunol | 2023 | 37207215 | PubTator, text mining | PubMed |
| Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma. | Front Immunol | 2023 | 37207207 | PubTator, text mining | PubMed |
| Increased Expression of SRSF1 Predicts Poor Prognosis in Multiple Myeloma. | J Oncol | 2023 | 37206090 | PubTator, text mining | PubMed |
| Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis. | PLoS Biol | 2023 | 37205711 | PubTator, text mining | PubMed |
| The application of autologous cancer immunotherapies in the age of memory-NK cells. | Front Immunol | 2023 | 37205105 | PubTator, text mining | PubMed |
| Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. | Ann Rheum Dis | 2023 | 37197892 | PubTator, text mining | PubMed |
| Investigation of the function of the novel tumor marker BEND5 in lung adenocarcinoma based on data mining and in vitro analysis. | J Thorac Dis | 2023 | 37197545 | PubTator, text mining | PubMed |
| Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells. | Biomedicines | 2023 | 37189725 | PubTator, text mining | PubMed |
| Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma. | Transl Oncol | 2023 | 37182508 | PubTator, text mining | PubMed |
| Recent advances in oncolytic virus therapy for hepatocellular carcinoma. | Front Oncol | 2023 | 37182136 | PubTator, text mining | PubMed |
| Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives. | Front Immunol | 2023 | 37180119 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8+ and CD4+ T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual. | Immune Netw | 2023 | 37179751 | PubTator, text mining | PubMed |
| Systemic Analyses of Cuproptosis-Related lncRNAs in Pancreatic Adenocarcinoma, with a Focus on the Molecular Mechanism of LINC00853. | Int J Mol Sci | 2023 | 37175629 | PubTator, text mining | PubMed |
| CCNF is a potential pancancer biomarker and immunotherapy target. | Front Oncol | 2023 | 37168372 | PubTator, text mining | PubMed |
| The emerging roles of long non-coding RNA in host immune response and intracellular bacterial infections. | Front Cell Infect Microbiol | 2023 | 37153158 | PubTator, text mining | PubMed |
| Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells. | Front Oncol | 2023 | 37152024 | PubTator, text mining | PubMed |
| Receptor-ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma. | Front Oncol | 2023 | 37152010 | PubTator, text mining | PubMed |
| Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells. | PLoS One | 2023 | 37146009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=24